Go to the Content   Saturday, 4 February 2012
 

EU to share anti-flu drugs

By Jennifer Rankin  -  30.04.2009 / 22:00 CET
EU steps up co-operation to curb swine flu, but rules out travel ban.

Please log in to read this article:

Log-in

Password

Forgot your password? Just type in your e-mail address and click on the Log In button

 

Don't have a login yet?

Discover your benefits and register for free now! It only takes a minute.

 Register for free

 

 

 

 

 

 

 

 

 

 

© 2012 European Voice. All rights reserved.
Varrow

Most viewed in Health & society

Ban on cadmium takes effect

Cadmium was added to banned list as part of the REACH chemicals legislation last year.

EU takes over biocides approval from member states

Authorisation regime will now be handled by the European Chemicals Agency.

'Inconclusive' data about breast implant risks

Commission report says more information needed on health risks from implants made by French firm.

business_implants_120112
Fact file

Measures agreed

EU ministers made several promises in the official conclusions to their meeting:

  • to share information about the virus;
  • to apply common definitions for defining a case of swine flu, or “novel flu” as the European Commission prefers to call it;
  • to work together to provide public information;
  • to co-operate on developing a vaccine covering the swine flu virus and look at the most quickest ways of producing it.

The three-page communication also included a statement that preparations and responses to health risks are ultimately a “member state competence”.

Related articles

Commission report says more information needed on health risks from implants made by French firm.

Authorisation regime will now be handled by the European Chemicals Agency.

Different reactions from member states to health scare.

Cadmium was added to banned list as part of the REACH chemicals legislation last year.

The EU must ensure that health inequalities do not widen during the financial crisis.

Advertisement

Comments

 

Your comment
Please note: The fields followed by an asterisk (*) are obligatory fields

Comment*

Name*
E-mail*
Website
 I accept the Terms & conditions
 I would like to share my e-mail & website

Advertisement

Disclaimer | Privacy policy | Terms & conditions